Sustained release dosage of thyrotropin-releasing hormone improves experimental Japanese encephalitis virus-induced parkinsonism in rats
Identifieur interne : 001E21 ( Main/Exploration ); précédent : 001E20; suivant : 001E22Sustained release dosage of thyrotropin-releasing hormone improves experimental Japanese encephalitis virus-induced parkinsonism in rats
Auteurs : Akihiko Ogata [Japon] ; Kazuo Nagashima [Japon] ; Kotaro Yasui [Japon] ; Tohru Matsuura [Japon] ; Kunio Tashiro [Japon]Source :
- Journal of the Neurological Sciences [ 0022-510X ] ; 1998.
Abstract
Thyrotropin-releasing hormone (TRH) has been reported to have some possibilities toward the treatment of affective CNS disorders. However, long term treatments with daily injections are often required. Effects of TRH-SR (sustained release microspheres of TRH) which is encapsulated in copoly (dl-lactic/glycolic acid) using an in-water drying method were investigated in experimental Japanese encephalitis virus (JEV)-induced post-encephalitic parkinsonism rats by a pole test and high performance liquid chromatography (HPLC) with an electrochemical detector (ECD). We have already reported that in adult Fischer rats killed 12 weeks after infection with JEV at the age of 13 days a marked decrease of tyrosine hydroxylase-positive neurons was found in the bilateral substantia nigra. TRH-SR (3 mg/kg per 2 weeks, 4 times injections, subcutaneous [SC]) improved bradykinesia observed in the JEV-induced parkinsonism rats. Dopamine (DA) concentrations in the JEV-infected rats were profoundly reduced in the striatum as compared with controls. TRH-SR (3 mg/kg, once, SC) increased DA in the striatum 7 days after the injection. Although the pathomechanism of post-encephalitic parkinsonism is different from that of Parkinson's disease and TRH possesses a variety of CNS effects as well, these results suggest that TRH-SR play a possible role in the treatment of Parkinson's disease in addition to post-encephalitic parkinsonism as a supportive drug of l-DOPA.
Url:
DOI: 10.1016/S0022-510X(98)00150-6
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Sustained release dosage of thyrotropin-releasing hormone improves experimental Japanese encephalitis virus-induced parkinsonism in rats</title><author><name sortKey="Ogata, Akihiko" sort="Ogata, Akihiko" uniqKey="Ogata A" first="Akihiko" last="Ogata">Akihiko Ogata</name></author><author><name sortKey="Nagashima, Kazuo" sort="Nagashima, Kazuo" uniqKey="Nagashima K" first="Kazuo" last="Nagashima">Kazuo Nagashima</name></author><author><name sortKey="Yasui, Kotaro" sort="Yasui, Kotaro" uniqKey="Yasui K" first="Kotaro" last="Yasui">Kotaro Yasui</name></author><author><name sortKey="Matsuura, Tohru" sort="Matsuura, Tohru" uniqKey="Matsuura T" first="Tohru" last="Matsuura">Tohru Matsuura</name></author><author><name sortKey="Tashiro, Kunio" sort="Tashiro, Kunio" uniqKey="Tashiro K" first="Kunio" last="Tashiro">Kunio Tashiro</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:DFE7CE8F18C308DF87F70FEAACECE86564B3B6CE</idno><date when="1998" year="1998">1998</date><idno type="doi">10.1016/S0022-510X(98)00150-6</idno><idno type="url">https://api.istex.fr/document/DFE7CE8F18C308DF87F70FEAACECE86564B3B6CE/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">003192</idno><idno type="wicri:Area/Main/Curation">002D90</idno><idno type="wicri:Area/Main/Exploration">001E21</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Sustained release dosage of thyrotropin-releasing hormone improves experimental Japanese encephalitis virus-induced parkinsonism in rats</title><author><name sortKey="Ogata, Akihiko" sort="Ogata, Akihiko" uniqKey="Ogata A" first="Akihiko" last="Ogata">Akihiko Ogata</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Hokkaido University School of Medicine, Sapporo</wicri:regionArea><wicri:noRegion>Sapporo</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Japon</country><wicri:regionArea>Corresponding author. Address for correspondence: Department of Neurology, Hokkaido University School of Medicine, North-14, West-5, Kita-ku, Sapporo, 060, Japan. Tel.: +81 11 7161161</wicri:regionArea><wicri:noRegion>Japan. Tel.: +81 11 7161161</wicri:noRegion></affiliation></author><author><name sortKey="Nagashima, Kazuo" sort="Nagashima, Kazuo" uniqKey="Nagashima K" first="Kazuo" last="Nagashima">Kazuo Nagashima</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Pathology, Hokkaido University School of Medicine, Sapporo</wicri:regionArea><wicri:noRegion>Sapporo</wicri:noRegion></affiliation></author><author><name sortKey="Yasui, Kotaro" sort="Yasui, Kotaro" uniqKey="Yasui K" first="Kotaro" last="Yasui">Kotaro Yasui</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Microbiology and Immunology, Tokyo Metropolitan Institute for Neuroscience, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Matsuura, Tohru" sort="Matsuura, Tohru" uniqKey="Matsuura T" first="Tohru" last="Matsuura">Tohru Matsuura</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Hokkaido University School of Medicine, Sapporo</wicri:regionArea><wicri:noRegion>Sapporo</wicri:noRegion></affiliation></author><author><name sortKey="Tashiro, Kunio" sort="Tashiro, Kunio" uniqKey="Tashiro K" first="Kunio" last="Tashiro">Kunio Tashiro</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Hokkaido University School of Medicine, Sapporo</wicri:regionArea><wicri:noRegion>Sapporo</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of the Neurological Sciences</title><title level="j" type="abbrev">JNS</title><idno type="ISSN">0022-510X</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1998">1998</date><biblScope unit="volume">159</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="135">135</biblScope><biblScope unit="page" to="139">139</biblScope></imprint><idno type="ISSN">0022-510X</idno></series><idno type="istex">DFE7CE8F18C308DF87F70FEAACECE86564B3B6CE</idno><idno type="DOI">10.1016/S0022-510X(98)00150-6</idno><idno type="PII">S0022-510X(98)00150-6</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0022-510X</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Thyrotropin-releasing hormone (TRH) has been reported to have some possibilities toward the treatment of affective CNS disorders. However, long term treatments with daily injections are often required. Effects of TRH-SR (sustained release microspheres of TRH) which is encapsulated in copoly (dl-lactic/glycolic acid) using an in-water drying method were investigated in experimental Japanese encephalitis virus (JEV)-induced post-encephalitic parkinsonism rats by a pole test and high performance liquid chromatography (HPLC) with an electrochemical detector (ECD). We have already reported that in adult Fischer rats killed 12 weeks after infection with JEV at the age of 13 days a marked decrease of tyrosine hydroxylase-positive neurons was found in the bilateral substantia nigra. TRH-SR (3 mg/kg per 2 weeks, 4 times injections, subcutaneous [SC]) improved bradykinesia observed in the JEV-induced parkinsonism rats. Dopamine (DA) concentrations in the JEV-infected rats were profoundly reduced in the striatum as compared with controls. TRH-SR (3 mg/kg, once, SC) increased DA in the striatum 7 days after the injection. Although the pathomechanism of post-encephalitic parkinsonism is different from that of Parkinson's disease and TRH possesses a variety of CNS effects as well, these results suggest that TRH-SR play a possible role in the treatment of Parkinson's disease in addition to post-encephalitic parkinsonism as a supportive drug of l-DOPA.</div></front></TEI><affiliations><list><country><li>Japon</li></country><settlement><li>Tokyo</li></settlement></list><tree><country name="Japon"><noRegion><name sortKey="Ogata, Akihiko" sort="Ogata, Akihiko" uniqKey="Ogata A" first="Akihiko" last="Ogata">Akihiko Ogata</name></noRegion><name sortKey="Matsuura, Tohru" sort="Matsuura, Tohru" uniqKey="Matsuura T" first="Tohru" last="Matsuura">Tohru Matsuura</name><name sortKey="Nagashima, Kazuo" sort="Nagashima, Kazuo" uniqKey="Nagashima K" first="Kazuo" last="Nagashima">Kazuo Nagashima</name><name sortKey="Ogata, Akihiko" sort="Ogata, Akihiko" uniqKey="Ogata A" first="Akihiko" last="Ogata">Akihiko Ogata</name><name sortKey="Tashiro, Kunio" sort="Tashiro, Kunio" uniqKey="Tashiro K" first="Kunio" last="Tashiro">Kunio Tashiro</name><name sortKey="Yasui, Kotaro" sort="Yasui, Kotaro" uniqKey="Yasui K" first="Kotaro" last="Yasui">Kotaro Yasui</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E21 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001E21 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:DFE7CE8F18C308DF87F70FEAACECE86564B3B6CE
|texte= Sustained release dosage of thyrotropin-releasing hormone improves experimental Japanese encephalitis virus-induced parkinsonism in rats
}}
| This area was generated with Dilib version V0.6.23. |  |